{"status": "Ok", "redirect_url": "https://www.prnewswire.com//news-releases/lilly-to-present-initial-clinical-data-for-first-in-class-type-ii-jak2-inhibitor-in-patients-with-previously-treated-myelofibrosis-at-the-2026-eha-annual-meeting-302799309.html", "message": "News view counter 798405 successfully enlarged"}